Cure from complexity
Innovative oncology drug discovery
At Awen Oncology, we aim to transform the landscape of cancer treatment.
Delivering first-in-class therapeutics that target novel, undrugged cancer-specific factors, offering new hope for patients around the world.
OUR MISSION
We are dedicated to discovering and developing innovative oncology treatments that address the complexities of cancer. By targeting specific proteins found only in cancer cells, we aim to create therapies with fewer side effects and improved efficacy.
Our Approach
Our unique methodology combines high-throughput cell and molecular biology with advanced computational techniques. This powerful synergy enables us to identify new therapeutic targets and develop effective treatments rapidly and efficiently.
Target Therapies
We have identified a number of cancer-specific oncogenic factors, targeting of which will produce breakthrough therapeutics, improving patient outcomes and reduce undesired side effects.
Working with strategic partners
Awen Oncology are working with an array of strategic partners to achieve our goals, including close ties with patient advocacy groups. We are also a newly appointed affiliate member of the University of Cambridge Milner Therapeutic Institute.
Invest in a healthier future
We invite investors and partners to join us in our journey to revolutionize cancer treatment. Together, we can make a profound difference in the lives of cancer patients.
Get in touch